nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—GALR3—head—thyroid cancer	0.0189	0.1	CbGeAlD
Dinoprost Tromethamine—TBXA2R—thyroid gland—thyroid cancer	0.0126	0.067	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—neck—thyroid cancer	0.0126	0.0667	CbGeAlD
Dinoprost Tromethamine—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.0117	0.0346	CcSEcCtD
Dinoprost Tromethamine—PTGER1—head—thyroid cancer	0.00981	0.0522	CbGeAlD
Dinoprost Tromethamine—PTGFR—trachea—thyroid cancer	0.0098	0.0521	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—saliva-secreting gland—thyroid cancer	0.00979	0.052	CbGeAlD
Dinoprost Tromethamine—PTGER3—thyroid gland—thyroid cancer	0.0097	0.0516	CbGeAlD
Dinoprost Tromethamine—Respiratory failure—Vandetanib—thyroid cancer	0.00884	0.0261	CcSEcCtD
Dinoprost Tromethamine—PTGER3—head—thyroid cancer	0.00861	0.0457	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—thyroid cancer	0.00783	0.0416	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—trachea—thyroid cancer	0.00755	0.0401	CbGeAlD
Dinoprost Tromethamine—Sepsis—Vandetanib—thyroid cancer	0.00754	0.0222	CcSEcCtD
Dinoprost Tromethamine—HPGDS—head—thyroid cancer	0.00744	0.0395	CbGeAlD
Dinoprost Tromethamine—PTGFR—head—thyroid cancer	0.00688	0.0366	CbGeAlD
Dinoprost Tromethamine—PTGIR—thyroid gland—thyroid cancer	0.00683	0.0363	CbGeAlD
Dinoprost Tromethamine—PTGIR—head—thyroid cancer	0.00606	0.0322	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—thyroid gland—thyroid cancer	0.00603	0.0321	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—thyroid cancer	0.00603	0.032	CbGeAlD
Dinoprost Tromethamine—Cardiac arrest—Vandetanib—thyroid cancer	0.00599	0.0177	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—thyroid gland—thyroid cancer	0.00597	0.0318	CbGeAlD
Dinoprost Tromethamine—Dehydration—Vandetanib—thyroid cancer	0.00586	0.0173	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Vandetanib—thyroid cancer	0.00574	0.0169	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Vandetanib—thyroid cancer	0.00536	0.0158	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—head—thyroid cancer	0.00535	0.0284	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—head—thyroid cancer	0.0053	0.0282	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymph node—thyroid cancer	0.00521	0.0277	CbGeAlD
Dinoprost Tromethamine—Dysuria—Vandetanib—thyroid cancer	0.00509	0.015	CcSEcCtD
Dinoprost Tromethamine—PTGFR—lymph node—thyroid cancer	0.00482	0.0256	CbGeAlD
Dinoprost Tromethamine—Urinary tract infection—Vandetanib—thyroid cancer	0.00472	0.0139	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00469	0.0138	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Vandetanib—thyroid cancer	0.00463	0.0137	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Vandetanib—thyroid cancer	0.00458	0.0135	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Vandetanib—thyroid cancer	0.00444	0.0131	CcSEcCtD
Dinoprost Tromethamine—PTGIR—lymph node—thyroid cancer	0.00425	0.0226	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—thyroid cancer	0.0041	1	CrCbGaD
Dinoprost Tromethamine—Venous thrombosis—Epirubicin—thyroid cancer	0.00401	0.0118	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Vandetanib—thyroid cancer	0.00396	0.0117	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Sorafenib—thyroid cancer	0.00395	0.0117	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Sorafenib—thyroid cancer	0.00387	0.0114	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lymph node—thyroid cancer	0.00375	0.0199	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—thyroid cancer	0.00371	0.0197	CbGeAlD
Dinoprost Tromethamine—Venous thrombosis—Doxorubicin—thyroid cancer	0.00371	0.0109	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Vandetanib—thyroid cancer	0.00365	0.0108	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Vandetanib—thyroid cancer	0.00334	0.00984	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—head—thyroid cancer	0.00333	0.0177	CbGeAlD
Dinoprost Tromethamine—Cough—Vandetanib—thyroid cancer	0.00331	0.00977	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Vandetanib—thyroid cancer	0.00329	0.0097	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Vandetanib—thyroid cancer	0.00328	0.00967	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Vandetanib—thyroid cancer	0.00323	0.00954	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Epirubicin—thyroid cancer	0.00315	0.00928	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Epirubicin—thyroid cancer	0.00312	0.00919	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Sorafenib—thyroid cancer	0.00309	0.00912	CcSEcCtD
Dinoprost Tromethamine—Infection—Vandetanib—thyroid cancer	0.00308	0.00908	CcSEcCtD
Dinoprost Tromethamine—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00292	0.00863	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Doxorubicin—thyroid cancer	0.00291	0.00859	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Doxorubicin—thyroid cancer	0.00288	0.00851	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Vandetanib—thyroid cancer	0.00278	0.00821	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Vandetanib—thyroid cancer	0.00276	0.00815	CcSEcCtD
Dinoprost Tromethamine—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00271	0.00799	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Sorafenib—thyroid cancer	0.00267	0.00788	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Sorafenib—thyroid cancer	0.00266	0.00784	CcSEcCtD
Dinoprost Tromethamine—Pain—Vandetanib—thyroid cancer	0.00265	0.00782	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Epirubicin—thyroid cancer	0.00263	0.00776	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00253	0.00748	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Epirubicin—thyroid cancer	0.00248	0.00732	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Sorafenib—thyroid cancer	0.00246	0.00726	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Vandetanib—thyroid cancer	0.00245	0.00723	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Vandetanib—thyroid cancer	0.00245	0.00723	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Doxorubicin—thyroid cancer	0.00243	0.00718	CcSEcCtD
Dinoprost Tromethamine—Syncope—Sorafenib—thyroid cancer	0.0023	0.00678	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Doxorubicin—thyroid cancer	0.0023	0.00677	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Sorafenib—thyroid cancer	0.00225	0.00664	CcSEcCtD
Dinoprost Tromethamine—Cough—Sorafenib—thyroid cancer	0.00223	0.00659	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vandetanib—thyroid cancer	0.00222	0.00656	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Sorafenib—thyroid cancer	0.00221	0.00652	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Vandetanib—thyroid cancer	0.00219	0.00647	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Epirubicin—thyroid cancer	0.00216	0.00639	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Epirubicin—thyroid cancer	0.00216	0.00639	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Vandetanib—thyroid cancer	0.00212	0.00625	CcSEcCtD
Dinoprost Tromethamine—Infection—Sorafenib—thyroid cancer	0.00208	0.00613	CcSEcCtD
Dinoprost Tromethamine—Shock—Sorafenib—thyroid cancer	0.00206	0.00607	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vandetanib—thyroid cancer	0.00205	0.00605	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Doxorubicin—thyroid cancer	0.002	0.00591	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Doxorubicin—thyroid cancer	0.002	0.00591	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vandetanib—thyroid cancer	0.00197	0.00581	CcSEcCtD
Dinoprost Tromethamine—Rash—Vandetanib—thyroid cancer	0.00195	0.00576	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vandetanib—thyroid cancer	0.00195	0.00576	CcSEcCtD
Dinoprost Tromethamine—Headache—Vandetanib—thyroid cancer	0.00194	0.00573	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Epirubicin—thyroid cancer	0.0019	0.0056	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Epirubicin—thyroid cancer	0.00188	0.00554	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Sorafenib—thyroid cancer	0.00186	0.0055	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vandetanib—thyroid cancer	0.00184	0.00543	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Epirubicin—thyroid cancer	0.00182	0.00538	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Epirubicin—thyroid cancer	0.00182	0.00536	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Epirubicin—thyroid cancer	0.00181	0.00533	CcSEcCtD
Dinoprost Tromethamine—Pain—Sorafenib—thyroid cancer	0.00179	0.00527	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—thyroid cancer	0.00176	0.00518	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Doxorubicin—thyroid cancer	0.00174	0.00513	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00173	0.00511	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00171	0.00504	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—thyroid cancer	0.00169	0.00498	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00168	0.00496	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00167	0.00493	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Sorafenib—thyroid cancer	0.00165	0.00487	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Sorafenib—thyroid cancer	0.00165	0.00487	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.0016	0.00473	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Epirubicin—thyroid cancer	0.00157	0.00464	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Sorafenib—thyroid cancer	0.00154	0.00454	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Sorafenib—thyroid cancer	0.0015	0.00442	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—thyroid cancer	0.00149	0.00441	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Sorafenib—thyroid cancer	0.00148	0.00436	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—thyroid cancer	0.00146	0.00431	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—thyroid cancer	0.00145	0.00429	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—thyroid cancer	0.00143	0.00422	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Sorafenib—thyroid cancer	0.00143	0.00422	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00138	0.00408	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Sorafenib—thyroid cancer	0.00138	0.00408	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—thyroid cancer	0.00135	0.00399	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Sorafenib—thyroid cancer	0.00133	0.00392	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—thyroid cancer	0.00132	0.0039	CcSEcCtD
Dinoprost Tromethamine—Rash—Sorafenib—thyroid cancer	0.00132	0.00389	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Sorafenib—thyroid cancer	0.00132	0.00388	CcSEcCtD
Dinoprost Tromethamine—Headache—Sorafenib—thyroid cancer	0.00131	0.00386	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Epirubicin—thyroid cancer	0.00127	0.00375	CcSEcCtD
Dinoprost Tromethamine—Nausea—Sorafenib—thyroid cancer	0.00124	0.00366	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Epirubicin—thyroid cancer	0.00121	0.00357	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—thyroid cancer	0.00118	0.00347	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—thyroid cancer	0.00118	0.00347	CcSEcCtD
Dinoprost Tromethamine—Sweating—Epirubicin—thyroid cancer	0.00116	0.00343	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—thyroid cancer	0.00115	0.00341	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—thyroid cancer	0.00114	0.00337	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—thyroid cancer	0.00112	0.00331	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—thyroid cancer	0.00111	0.00327	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—thyroid cancer	0.00109	0.00321	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—thyroid cancer	0.00107	0.00317	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—thyroid cancer	0.00107	0.00315	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—thyroid cancer	0.00106	0.00312	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—thyroid cancer	0.00102	0.00302	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—thyroid cancer	0.000986	0.00291	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—thyroid cancer	0.000982	0.0029	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—thyroid cancer	0.000975	0.00288	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—thyroid cancer	0.000915	0.0027	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—thyroid cancer	0.000913	0.00269	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—thyroid cancer	0.00091	0.00268	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—thyroid cancer	0.000909	0.00268	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—thyroid cancer	0.000903	0.00266	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000878	0.00259	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—thyroid cancer	0.00087	0.00257	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—thyroid cancer	0.000853	0.00252	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—thyroid cancer	0.000849	0.0025	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—thyroid cancer	0.000847	0.0025	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—thyroid cancer	0.000842	0.00248	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—thyroid cancer	0.000832	0.00245	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—thyroid cancer	0.000826	0.00244	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—thyroid cancer	0.00082	0.00242	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—thyroid cancer	0.000817	0.00241	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000812	0.0024	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—thyroid cancer	0.000806	0.00238	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—thyroid cancer	0.000805	0.00237	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—thyroid cancer	0.000796	0.00235	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—thyroid cancer	0.00079	0.00233	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—thyroid cancer	0.000785	0.00232	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00077	0.00227	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—thyroid cancer	0.000767	0.00226	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—thyroid cancer	0.000764	0.00225	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—thyroid cancer	0.00076	0.00224	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—thyroid cancer	0.000759	0.00224	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—thyroid cancer	0.000756	0.00223	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—thyroid cancer	0.000754	0.00222	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000747	0.0022	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—thyroid cancer	0.000745	0.0022	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—thyroid cancer	0.000737	0.00217	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—thyroid cancer	0.000722	0.00213	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—thyroid cancer	0.00071	0.00209	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—thyroid cancer	0.000703	0.00207	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—thyroid cancer	0.000697	0.00206	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—thyroid cancer	0.000694	0.00205	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000691	0.00204	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—thyroid cancer	0.000689	0.00203	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—thyroid cancer	0.000687	0.00203	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—thyroid cancer	0.000668	0.00197	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—thyroid cancer	0.00066	0.00195	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—thyroid cancer	0.000642	0.00189	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—thyroid cancer	0.000637	0.00188	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—thyroid cancer	0.000636	0.00188	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—thyroid cancer	0.000635	0.00187	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000632	0.00186	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—thyroid cancer	0.000611	0.0018	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—thyroid cancer	0.000611	0.0018	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—thyroid cancer	0.000611	0.0018	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—TPR—thyroid cancer	0.000609	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000609	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—SST—thyroid cancer	0.000607	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PTCH1—thyroid cancer	0.000603	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PRKAR1A—thyroid cancer	0.000599	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TSHR—thyroid cancer	0.000599	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000598	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IFNA2—thyroid cancer	0.000589	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000589	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000589	0.00174	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CALCA—thyroid cancer	0.000588	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CALCA—thyroid cancer	0.000584	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000584	0.00172	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—TSHR—thyroid cancer	0.000584	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000579	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—CP—thyroid cancer	0.000579	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TCF7L1—thyroid cancer	0.000572	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—TSHR—thyroid cancer	0.000571	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—TSHR—thyroid cancer	0.000571	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00057	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—thyroid cancer	0.000569	0.00168	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000568	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—thyroid cancer	0.000565	0.00167	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—thyroid cancer	0.000565	0.00167	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MEN1—thyroid cancer	0.000563	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Epirubicin—thyroid cancer	0.000554	0.00164	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—SST—thyroid cancer	0.000551	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Epirubicin—thyroid cancer	0.000546	0.00161	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000543	0.00116	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CDK1—thyroid cancer	0.000533	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CALCA—thyroid cancer	0.000531	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—TSHR—thyroid cancer	0.00053	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—thyroid cancer	0.000528	0.00156	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000527	0.00155	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000522	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—TSHR—thyroid cancer	0.000519	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—TSHR—thyroid cancer	0.000519	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000514	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Doxorubicin—thyroid cancer	0.000513	0.00151	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—thyroid cancer	0.000511	0.00151	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000511	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000511	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTCH1—thyroid cancer	0.000509	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Doxorubicin—thyroid cancer	0.000506	0.00149	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000499	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Epirubicin—thyroid cancer	0.000491	0.00145	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—thyroid cancer	0.000489	0.00144	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—thyroid cancer	0.000487	0.00144	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000487	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000487	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—Dermatitis—Epirubicin—thyroid cancer	0.000487	0.00144	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—thyroid cancer	0.000484	0.00143	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000483	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CDK1—thyroid cancer	0.00048	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000479	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000478	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Doxorubicin—thyroid cancer	0.000473	0.00139	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SST—thyroid cancer	0.000466	0.000993	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TSHR—thyroid cancer	0.000464	0.00099	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Epirubicin—thyroid cancer	0.000459	0.00135	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PRKAR1A—thyroid cancer	0.000457	0.000974	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—SLC5A5—thyroid cancer	0.000456	0.000972	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Doxorubicin—thyroid cancer	0.000454	0.00134	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—SST—thyroid cancer	0.000454	0.000968	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PTCH1—thyroid cancer	0.000451	0.000961	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Doxorubicin—thyroid cancer	0.000451	0.00133	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—thyroid cancer	0.00045	0.00133	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CALCA—thyroid cancer	0.000448	0.000956	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Doxorubicin—thyroid cancer	0.000448	0.00132	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000445	0.00095	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—SST—thyroid cancer	0.000444	0.000948	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—SST—thyroid cancer	0.000444	0.000948	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PTCH1—thyroid cancer	0.000441	0.000941	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PTCH1—thyroid cancer	0.000441	0.000941	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CALCA—thyroid cancer	0.000437	0.000932	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MEN1—thyroid cancer	0.000437	0.000931	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000436	0.00093	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000433	0.000924	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MINPP1—thyroid cancer	0.000428	0.000914	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TCF7L1—thyroid cancer	0.000428	0.000913	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CALCA—thyroid cancer	0.000428	0.000912	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CALCA—thyroid cancer	0.000428	0.000912	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000427	0.000911	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Doxorubicin—thyroid cancer	0.000424	0.00125	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TCF7L1—thyroid cancer	0.000419	0.000893	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TCF7L1—thyroid cancer	0.000419	0.000893	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TSHR—thyroid cancer	0.000419	0.000893	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000417	0.00089	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—SST—thyroid cancer	0.000412	0.000879	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000412	0.000879	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000406	0.000866	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000406	0.000866	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CDK1—thyroid cancer	0.000406	0.000865	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—SST—thyroid cancer	0.000404	0.000861	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—SST—thyroid cancer	0.000404	0.000861	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000401	0.000856	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.0004	0.000852	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CALCA—thyroid cancer	0.000397	0.000846	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTCH1—thyroid cancer	0.000395	0.000842	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MEN1—thyroid cancer	0.000394	0.00084	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CALCA—thyroid cancer	0.000388	0.000828	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CALCA—thyroid cancer	0.000388	0.000828	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000383	0.000817	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—RXRA—thyroid cancer	0.000383	0.000817	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000375	0.0008	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000372	0.000794	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NDUFA13—thyroid cancer	0.000364	0.000777	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000364	0.000777	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000364	0.000777	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SST—thyroid cancer	0.000361	0.00077	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CDK1—thyroid cancer	0.000359	0.000766	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTCH1—thyroid cancer	0.000356	0.000759	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CDK1—thyroid cancer	0.000352	0.00075	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CDK1—thyroid cancer	0.000352	0.00075	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CALCA—thyroid cancer	0.000348	0.000741	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CHST14—thyroid cancer	0.000343	0.000731	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000339	0.000722	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000339	0.000722	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000333	0.00071	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—NRAS—thyroid cancer	0.000333	0.00071	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000326	0.000695	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NRG1—thyroid cancer	0.000326	0.000695	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SST—thyroid cancer	0.000326	0.000695	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000319	0.00068	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000318	0.000678	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDK1—thyroid cancer	0.000315	0.000671	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CALCA—thyroid cancer	0.000314	0.000669	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TSHR—thyroid cancer	0.000313	0.000668	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PRKAR1A—thyroid cancer	0.000308	0.000657	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TSHR—thyroid cancer	0.000307	0.000654	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TSHR—thyroid cancer	0.000307	0.000654	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000306	0.000653	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000304	0.000648	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PRKAR1A—thyroid cancer	0.000302	0.000643	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000302	0.000643	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MEN1—thyroid cancer	0.000294	0.000628	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TERT—thyroid cancer	0.000292	0.000624	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MEN1—thyroid cancer	0.000288	0.000615	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MEN1—thyroid cancer	0.000288	0.000615	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—KRAS—thyroid cancer	0.000287	0.000611	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDK1—thyroid cancer	0.000284	0.000605	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HIF1A—thyroid cancer	0.00028	0.000596	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HPGD—thyroid cancer	0.000276	0.000589	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTCH1—thyroid cancer	0.000266	0.000568	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTCH1—thyroid cancer	0.000261	0.000556	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTCH1—thyroid cancer	0.000261	0.000556	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000255	0.000545	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—thyroid cancer	0.000255	0.000543	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000253	0.000541	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRG1—thyroid cancer	0.000253	0.000539	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—NRAS—thyroid cancer	0.000246	0.000525	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—BRAF—thyroid cancer	0.000244	0.000519	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SST—thyroid cancer	0.000244	0.000519	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—HRAS—thyroid cancer	0.000244	0.000519	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PPARG—thyroid cancer	0.000242	0.000516	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SST—thyroid cancer	0.000238	0.000508	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SST—thyroid cancer	0.000238	0.000508	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CALCA—thyroid cancer	0.000234	0.0005	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—BRAF—thyroid cancer	0.000232	0.000494	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CALCA—thyroid cancer	0.000229	0.000489	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CALCA—thyroid cancer	0.000229	0.000489	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRG1—thyroid cancer	0.000228	0.000486	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TERT—thyroid cancer	0.000227	0.000484	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NRAS—thyroid cancer	0.00022	0.000469	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HIF1A—thyroid cancer	0.000217	0.000462	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—AKT1—thyroid cancer	0.000215	0.000459	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000213	0.000454	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDK1—thyroid cancer	0.000212	0.000453	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—KRAS—thyroid cancer	0.000212	0.000452	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDK1—thyroid cancer	0.000208	0.000443	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDK1—thyroid cancer	0.000208	0.000443	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TERT—thyroid cancer	0.000205	0.000436	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HIF1A—thyroid cancer	0.000196	0.000417	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—NRAS—thyroid cancer	0.000191	0.000407	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—thyroid cancer	0.00019	0.000406	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—KRAS—thyroid cancer	0.000189	0.000403	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HRAS—thyroid cancer	0.00018	0.000384	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—BRAF—thyroid cancer	0.00018	0.000383	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—AKT1—thyroid cancer	0.000175	0.000374	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—NRAS—thyroid cancer	0.000172	0.000368	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRG1—thyroid cancer	0.00017	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCND1—thyroid cancer	0.000169	0.00036	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—thyroid cancer	0.000168	0.000359	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRG1—thyroid cancer	0.000167	0.000356	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRG1—thyroid cancer	0.000167	0.000356	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTEN—thyroid cancer	0.000166	0.000354	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—KRAS—thyroid cancer	0.000164	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTEN—thyroid cancer	0.000163	0.000348	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—BRAF—thyroid cancer	0.000162	0.000345	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—thyroid cancer	0.000161	0.000343	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKT1—thyroid cancer	0.000159	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TPR—thyroid cancer	0.000159	0.000338	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	0.000156	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TERT—thyroid cancer	0.000153	0.000326	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TERT—thyroid cancer	0.00015	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TERT—thyroid cancer	0.00015	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—KRAS—thyroid cancer	0.000148	0.000316	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—thyroid cancer	0.000146	0.000312	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000146	0.000312	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NRAS—thyroid cancer	0.000146	0.00031	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—thyroid cancer	0.000143	0.000305	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HIF1A—thyroid cancer	0.000143	0.000305	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—AKT1—thyroid cancer	0.000142	0.000303	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—thyroid cancer	0.00014	0.000298	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—thyroid cancer	0.000136	0.00029	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—thyroid cancer	0.000131	0.00028	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—thyroid cancer	0.000129	0.000275	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTEN—thyroid cancer	0.000126	0.00027	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—NRAS—thyroid cancer	0.000126	0.000269	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—thyroid cancer	0.000126	0.000269	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—thyroid cancer	0.000126	0.000269	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—thyroid cancer	0.000125	0.000267	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—thyroid cancer	0.000123	0.000263	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—thyroid cancer	0.000123	0.000261	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—BRAF—thyroid cancer	0.000121	0.000258	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	0.000119	0.000253	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—BRAF—thyroid cancer	0.000119	0.000253	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—BRAF—thyroid cancer	0.000119	0.000253	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—thyroid cancer	0.000118	0.000252	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTEN—thyroid cancer	0.000114	0.000243	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRAS—thyroid cancer	0.000113	0.000241	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—thyroid cancer	0.000112	0.000239	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—thyroid cancer	0.000111	0.000237	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—thyroid cancer	0.000111	0.000237	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—thyroid cancer	0.000111	0.000237	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—thyroid cancer	0.000109	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—thyroid cancer	0.000109	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—thyroid cancer	0.000106	0.000227	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRAS—thyroid cancer	0.000102	0.000217	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—RXRA—thyroid cancer	9.97e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—thyroid cancer	9.71e-05	0.000207	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—thyroid cancer	9.56e-05	0.000204	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—thyroid cancer	9.43e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—thyroid cancer	9.4e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—thyroid cancer	9.23e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—thyroid cancer	9.23e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—thyroid cancer	9.17e-05	0.000195	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—thyroid cancer	8.97e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—thyroid cancer	8.97e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—thyroid cancer	8.84e-05	0.000189	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—thyroid cancer	8.76e-05	0.000187	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—thyroid cancer	8.65e-05	0.000185	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—thyroid cancer	8.65e-05	0.000185	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—thyroid cancer	8.63e-05	0.000184	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTEN—thyroid cancer	8.53e-05	0.000182	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTEN—thyroid cancer	8.35e-05	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTEN—thyroid cancer	8.35e-05	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—thyroid cancer	8.32e-05	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—thyroid cancer	8.26e-05	0.000176	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—thyroid cancer	8.15e-05	0.000174	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—thyroid cancer	8.15e-05	0.000174	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—thyroid cancer	7.79e-05	0.000166	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRAS—thyroid cancer	7.61e-05	0.000162	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRAS—thyroid cancer	7.45e-05	0.000159	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRAS—thyroid cancer	7.45e-05	0.000159	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—thyroid cancer	7.45e-05	0.000159	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—thyroid cancer	7.29e-05	0.000155	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—thyroid cancer	6.58e-05	0.00014	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—thyroid cancer	6.55e-05	0.00014	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—thyroid cancer	6.41e-05	0.000137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—thyroid cancer	6.41e-05	0.000137	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARG—thyroid cancer	6.3e-05	0.000134	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—thyroid cancer	5.82e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—thyroid cancer	5.7e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—thyroid cancer	5.7e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—thyroid cancer	5.57e-05	0.000119	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—thyroid cancer	5.45e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—thyroid cancer	5.45e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—thyroid cancer	4.95e-05	0.000106	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—thyroid cancer	4.92e-05	0.000105	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—thyroid cancer	4.81e-05	0.000103	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—thyroid cancer	4.81e-05	0.000103	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTEN—thyroid cancer	4.32e-05	9.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—thyroid cancer	2.49e-05	5.31e-05	CbGpPWpGaD
